HOWL$1.022.93%0.0289
Werewolf Therapeutics Inc (HOWL)
Date: 2026-11-02 16:00O: 1.01H: 1.04L: 1.00C: 1.02Vol: 100.0k
Werewolf Therapeutics Inc stock is traded at $1.02, with a volume of 110,903. It is up +2.93% in the last 24 hours and up +9.36% over the past month. Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Previous Close:
$0.9861
Open:
$1.01
24h Volume:
110,903
Relative Volume:
0.32
Market Cap:
$49.33M
Revenue:
$1.14M
Net Income/Loss:
-$56.27M
P/E Ratio:
-
EPS:
-$1.21
Net Cash Flow:
-$51.94M
1W Performance:
+3.51%
1M Performance:
+9.36%
6M Performance:
+40.39%
1Y Performance:
-22.52%
1-Day Range:
$1.00$1.04
1-Week Range:
$0.96$1.10
52-Week Range:
$0.27$1.55
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
617-952-0555Address
200 TALCOTT AVENUE, WATERTOWN, USACompare HOWL vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
HOWL Werewolf Therapeutics Inc | $49.33M | $0 | -$34.61M | -$51.94M | -$1.21 |
 VRTX Vertex Pharmaceuticals Inc | $142.75B | $12.59B | $4.41B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.64B | $16.90B | $4.82B | $3.79B | $41.04 |
 MRNA Moderna Inc | $88.51B | $2.23B | -$3.15B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $55.37B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $41.12B | $6.13B | $655.71M | $1.10B | $4.48 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Werewolf Therapeutics Inc Stock (HOWL) Insider Trading
- EVNIN LUKEJul 06 '26Director
- Transaction
- Sale
- Cost
- $0.32
- #Shares
- 35,770
- Value ($)
- 11,446
- #Shares Total
- 107,429
- MPM BioVentures 2014, L.P.Jul 06 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.34
- #Shares
- 96,873
- Value ($)
- 32,976
- #Shares Total
- 0
- MPM BioVentures 2014 (B), L.P.Jul 06 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.34
- #Shares
- 6,459
- Value ($)
- 2,199
- #Shares Total
- 0
- UBS Oncology Impact Fund, L.P.Jul 06 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.34
- #Shares
- 80,142
- Value ($)
- 27,280
- #Shares Total
- 0
- MPM Asset Management LLCJul 06 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.34
- #Shares
- 15,341
- Value ($)
- 5,222
- #Shares Total
- 0
- MPM Asset Management InvestorsJul 06 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.34
- #Shares
- 3,332
- Value ($)
- 1,134
- #Shares Total
- 0
- MPM Oncology Innovations Fund,Jul 06 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.34
- #Shares
- 21,194
- Value ($)
- 7,214
- #Shares Total
- 0
- MPM BioVentures 2014 (B), L.P.Jun 29 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.32
- #Shares
- 7,087
- Value ($)
- 2,289
- #Shares Total
- 0
- MPM Asset Management LLCJun 29 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.32
- #Shares
- 16,830
- Value ($)
- 5,436
- #Shares Total
- 0
- MPM Oncology Innovations Fund,Jun 29 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $0.32
- #Shares
- 23,248
- Value ($)
- 7,509
- #Shares Total
- 0
